Ticker
SBFMCompany Name
SUNSHINE BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 27.85M | $ 5.57M | $ 22.28M |
3/31/2025 | $ 24.48M | $ 5.76M | $ 18.72M |
12/31/2024 | $ 25.97M | $ 6.31M | $ 19.65M |
9/30/2024 | $ 25.98M | $ 4.53M | $ 21.45M |
6/30/2024 | $ 25.75M | $ 5.3M | $ 20.45M |
3/31/2024 | $ 28.83M | $ 6.53M | $ 22.3M |
12/31/2023 | $ 24.89M | $ 5.55M | $ 19.34M |
9/30/2023 | $ 25.43M | $ 5.09M | $ 20.35M |
6/30/2023 | $ 26.1M | $ 4.66M | $ 21.44M |
3/31/2023 | $ 24.95M | $ 6.91M | $ 18.04M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for SUNSHINE BIOPHARMA INC is calculated as follows: AssetsC [ $ 1.03M ] - LiabilitesC [ $ 1.05M ]
(=) Working Capital [ $ -25.36K ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.6M |
median | $ 32.21M |
std | $ 173.49M |